Sarcopenia indicate poor survival in patients undergoing transarterial chemoembolization (TACE) for hepatic malignancies

BACKGROUND: Patient selection for transarterial chemoembolization (TACE) has remained challenging. Currently used markers mainly reflect liver function and turned out as less reliable in larger clinical trials. The patients´ body composition has been linked with patient outcome in different cancers....

Descripción completa

Detalles Bibliográficos
Autores principales: Loosen, Sven H., Jördens, Markus S., Schoon, Berenike, Antoch, Gerald, Luedde, Tom, Minko, Peter, Loberg, Christina, Roderburg, Christoph
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10356883/
https://www.ncbi.nlm.nih.gov/pubmed/36689060
http://dx.doi.org/10.1007/s00432-022-04519-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10356883/
https://www.ncbi.nlm.nih.gov/pubmed/36689060
http://dx.doi.org/10.1007/s00432-022-04519-8

Ejemplares similares